These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20189387)

  • 21. Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
    Napier SE; Letourneau JJ; Ansari N; Auld DS; Baker J; Best S; Campbell-Wan L; Chan JH; Craighead M; Desai H; Goan KA; Ho KK; Hulskotte EG; MacSweeney CP; Milne R; Morphy JR; Neagu I; Ohlmeyer MH; Peeters AW; Presland J; Riviello C; Ruigt GS; Thomson FJ; Zanetakos HA; Zhao J; Webb ML
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1871-5. PubMed ID: 21353540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.
    Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z
    J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.
    Johnson SG; Gunnet JW; Moore JB; Miller W; Wines P; Rivero RA; Combs D; Demarest KT
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3362-6. PubMed ID: 16650762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
    Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
    J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
    Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
    J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amides as bioisosteres of triazole-based geranylgeranyl diphosphate synthase inhibitors.
    Goetz DB; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2020 Aug; 28(16):115604. PubMed ID: 32690260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioisosteric Replacement of Amide Group with 1,2,3-Triazoles in Acetaminophen Addresses Reactive Oxygen Species-Mediated Hepatotoxic Insult in Wistar Albino Rats.
    Sahu A; Das D; Sahu P; Mishra S; Sakthivel A; Gajbhiye A; Agrawal R
    Chem Res Toxicol; 2020 Feb; 33(2):522-535. PubMed ID: 31849220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the control of apoptosis by amide/triazole isosteric substitution in a constrained peptoid.
    Corredor M; Bujons J; Orzáez M; Sancho M; Pérez-Payá E; Alfonso I; Messeguer A
    Eur J Med Chem; 2013 May; 63():892-6. PubMed ID: 23624308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biaryl amide glucagon receptor antagonists.
    Kurukulasuriya R; Sorensen BK; Link JT; Patel JR; Jae HS; Winn MX; Rohde JR; Grihalde ND; Lin CW; Ogiela CA; Adler AL; Collins CA
    Bioorg Med Chem Lett; 2004 May; 14(9):2047-50. PubMed ID: 15080976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The characterization of a novel V1b antagonist lead series.
    Smethurst CA; Borthwick JA; Gaines S; Watson S; Green A; Schulz MJ; Burton G; Buson AA; Arban R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):92-6. PubMed ID: 21146408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
    Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
    J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional architecture of vasopressin/oxytocin receptors.
    Hibert M; Hoflack J; Trumpp-Kallmeyer S; Mouillac B; Chini B; Mahé E; Cotte N; Jard S; Manning M; Barberis C
    J Recept Signal Transduct Res; 1999; 19(1-4):589-96. PubMed ID: 10071787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists.
    Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; O'Neill K; Hawes B
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5234-6. PubMed ID: 16202583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and optimisation of a potent and selective tertiary sulfonamide oxytocin antagonist.
    Barton NP; Bellenie BR; Doran AT; Emmons AJ; Heer JP; Salvagno CM
    Bioorg Med Chem Lett; 2009 Jan; 19(2):528-32. PubMed ID: 19081251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations.
    Guillon G; Derick S; Pena A; Cheng LL; Stoev S; Seyer R; Morgat JL; Barberis C; Gal CS; Wagnon J; Manning M
    J Neuroendocrinol; 2004 Apr; 16(4):356-61. PubMed ID: 15089974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of amides of 2,4-dioxothiazolidin-5-yl acetic acid with 1,2,4-triazole substituents.
    Trotsko N; Dobosz M; Chodkowska A; Jagiełło-Wójtowicz E
    Acta Pol Pharm; 2008; 65(2):217-21. PubMed ID: 18666428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.